Fingerprint
Dive into the research topics of 'Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically